Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biointerphases ; 17(6): 061001, 2022 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-36323527

RESUMEN

RNA-based therapeutics hold a great promise in treating a variety of diseases. However, double-stranded RNAs (dsRNAs) are inherently unstable, highly charged, and stiff macromolecules that require a delivery vehicle. Cationic ligand functionalized gold nanoparticles (AuNPs) are able to compact nucleic acids and assist in RNA delivery. Here, we use large-scale all-atom molecular dynamics simulations to show that correlations between ligand length, metal core size, and ligand excess free volume control the ability of nanoparticles to bend dsRNA far below its persistence length. The analysis of ammonium binding sites showed that longer ligands that bind deep within the major groove did not cause bending. By limiting ligand length and, thus, excess free volume, we have designed nanoparticles with controlled internal binding to RNA's major groove. NPs that are able to induce RNA bending cause a periodic variation in RNA's major groove width. Density functional theory studies on smaller models support large-scale simulations. Our results are expected to have significant implications in packaging of nucleic acids for their applications in nanotechnology and gene delivery.


Asunto(s)
Nanopartículas del Metal , Ácidos Nucleicos , Oro/química , ARN , Nanopartículas del Metal/química , Ligandos , Ácidos Nucleicos/metabolismo
2.
Biointerphases ; 13(6): 06D502, 2018 11 21.
Artículo en Inglés | MEDLINE | ID: mdl-30463411

RESUMEN

Ligand-functionalized inorganic nanoparticles, also known as monolayer-protected nanoparticles, offer great potential as vehicles for in vivo delivery of drugs, genes, and other therapeutics. These nanoparticles offer highly customizable chemistries independent of the size, shape, and functionality imparted by the inorganic core. Their success as drug delivery agents depends on their interaction with three major classes of biomolecules: nucleic acids, proteins, and membranes. Here, the authors discuss recent advances and open questions in the field of nanoparticle ligand design for nanomedicine, with a focus on atomic-scale interactions with biomolecules. While the importance of charge and hydrophobicity of ligands for biocompatibility and cell internalization has been demonstrated, ligand length, flexibility, branchedness, and other properties also influence the properties of nanoparticles. However, a comprehensive understanding of ligand design principles lies in the cost associated with synthesizing and characterizing diverse ligand chemistries and the ability to carefully assess the structural integrity of biomolecules upon interactions with nanoparticles.


Asunto(s)
Portadores de Fármacos/química , Nanomedicina/métodos , Nanopartículas/química , Propiedades de Superficie , Tecnología Farmacéutica/métodos , Humanos , Nanomedicina/economía , Nanomedicina/tendencias , Tecnología Farmacéutica/economía , Tecnología Farmacéutica/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA